234 related articles for article (PubMed ID: 9484373)
21. High-dose riboflavin treatment is efficacious in migraine prophylaxis: an open study in a tertiary care centre.
Boehnke C; Reuter U; Flach U; Schuh-Hofer S; Einhäupl KM; Arnold G
Eur J Neurol; 2004 Jul; 11(7):475-7. PubMed ID: 15257686
[TBL] [Abstract][Full Text] [Related]
22. Speed of onset and efficacy of zolmitriptan nasal spray in the acute treatment of migraine: a randomised, double-blind, placebo-controlled, dose-ranging study versus zolmitriptan tablet.
Charlesworth BR; Dowson AJ; Purdy A; Becker WJ; Boes-Hansen S; Färkkilä M
CNS Drugs; 2003; 17(9):653-67. PubMed ID: 12828501
[TBL] [Abstract][Full Text] [Related]
23. Acupuncture for the prevention of episodic migraine.
Linde K; Allais G; Brinkhaus B; Fei Y; Mehring M; Vertosick EA; Vickers A; White AR
Cochrane Database Syst Rev; 2016 Jun; 2016(6):CD001218. PubMed ID: 27351677
[TBL] [Abstract][Full Text] [Related]
24. Oxcarbazepine in migraine headache: a double-blind, randomized, placebo-controlled study.
Silberstein S; Saper J; Berenson F; Somogyi M; McCague K; D'Souza J
Neurology; 2008 Feb; 70(7):548-55. PubMed ID: 18268247
[TBL] [Abstract][Full Text] [Related]
25. Efficacy and tolerability of acetazolamide in migraine prophylaxis: a randomised placebo-controlled trial.
Vahedi K; Taupin P; Djomby R; El-Amrani M; Lutz G; Filipetti V; Landais P; Massiou H; Bousser MG;
J Neurol; 2002 Feb; 249(2):206-11. PubMed ID: 11985388
[TBL] [Abstract][Full Text] [Related]
26. Safety and efficacy of LY2951742, a monoclonal antibody to calcitonin gene-related peptide, for the prevention of migraine: a phase 2, randomised, double-blind, placebo-controlled study.
Dodick DW; Goadsby PJ; Spierings EL; Scherer JC; Sweeney SP; Grayzel DS
Lancet Neurol; 2014 Sep; 13(9):885-92. PubMed ID: 25127173
[TBL] [Abstract][Full Text] [Related]
27. Sodium valproate has a prophylactic effect in migraine without aura: a triple-blind, placebo-controlled crossover study.
Jensen R; Brinck T; Olesen J
Neurology; 1994 Apr; 44(4):647-51. PubMed ID: 8164818
[TBL] [Abstract][Full Text] [Related]
28. Supplementation with Riboflavin (Vitamin B2) for Migraine Prophylaxis in Adults and Children: A Review.
Namazi N; Heshmati J; Tarighat-Esfanjani A
Int J Vitam Nutr Res; 2015; 85(1-2):79-87. PubMed ID: 26780280
[TBL] [Abstract][Full Text] [Related]
29. OnabotulinumtoxinA for treatment of chronic migraine: pooled analyses of the 56-week PREEMPT clinical program.
Aurora SK; Winner P; Freeman MC; Spierings EL; Heiring JO; DeGryse RE; VanDenburgh AM; Nolan ME; Turkel CC
Headache; 2011 Oct; 51(9):1358-73. PubMed ID: 21883197
[TBL] [Abstract][Full Text] [Related]
30. An observational study of fixed-dose Tanacetum parthenium nutraceutical preparation for prophylaxis of pediatric headache.
Moscano F; Guiducci M; Maltoni L; Striano P; Ledda MG; Zoroddu F; Raucci U; Villa MP; Parisi P
Ital J Pediatr; 2019 Mar; 45(1):36. PubMed ID: 30871574
[TBL] [Abstract][Full Text] [Related]
31. Efficacy and safety of topiramate for the treatment of chronic migraine: a randomized, double-blind, placebo-controlled trial.
Silberstein SD; Lipton RB; Dodick DW; Freitag FG; Ramadan N; Mathew N; Brandes JL; Bigal M; Saper J; Ascher S; Jordan DM; Greenberg SJ; Hulihan J;
Headache; 2007 Feb; 47(2):170-80. PubMed ID: 17300356
[TBL] [Abstract][Full Text] [Related]
32. Comparison of propranolol LA 80 mg and propranolol LA 160 mg in migraine prophylaxis: a placebo controlled study.
al-Qassab HK; Findley LJ
Cephalalgia; 1993 Apr; 13(2):128-31. PubMed ID: 8495455
[TBL] [Abstract][Full Text] [Related]
33. Improvement of migraine symptoms with a proprietary supplement containing riboflavin, magnesium and Q10: a randomized, placebo-controlled, double-blind, multicenter trial.
Gaul C; Diener HC; Danesch U;
J Headache Pain; 2015; 16():516. PubMed ID: 25916335
[TBL] [Abstract][Full Text] [Related]
34. Differential effectiveness of placebo treatments: a systematic review of migraine prophylaxis.
Meissner K; Fässler M; Rücker G; Kleijnen J; Hróbjartsson A; Schneider A; Antes G; Linde K
JAMA Intern Med; 2013 Nov; 173(21):1941-51. PubMed ID: 24126676
[TBL] [Abstract][Full Text] [Related]
35. Low-dose sodium valproate versus low-dose propranolol in prophylaxis of common migraine headache: A randomized, prospective, parallel, open-label study.
Dakhale GN; Sharma VS; Thakre MN; Kalikar M
Indian J Pharmacol; 2019; 51(4):255-262. PubMed ID: 31571712
[TBL] [Abstract][Full Text] [Related]
36. Safety and efficacy of galcanezumab in patients for whom previous migraine preventive medication from two to four categories had failed (CONQUER): a multicentre, randomised, double-blind, placebo-controlled, phase 3b trial.
Mulleners WM; Kim BK; Láinez MJA; Lanteri-Minet M; Pozo-Rosich P; Wang S; Tockhorn-Heidenreich A; Aurora SK; Nichols RM; Yunes-Medina L; Detke HC
Lancet Neurol; 2020 Oct; 19(10):814-825. PubMed ID: 32949542
[TBL] [Abstract][Full Text] [Related]
37. Retrospective Observational Study on Riboflavin Prophylaxis in Child and Adolescent Migraine.
Das R; Qubty W
Pediatr Neurol; 2021 Jan; 114():5-8. PubMed ID: 33189027
[TBL] [Abstract][Full Text] [Related]
38. Role of magnesium, coenzyme Q10, riboflavin, and vitamin B12 in migraine prophylaxis.
Bianchi A; Salomone S; Caraci F; Pizza V; Bernardini R; D'Amato CC
Vitam Horm; 2004; 69():297-312. PubMed ID: 15196887
[TBL] [Abstract][Full Text] [Related]
39. Efficacy and tolerability of sumatriptan tablets in a fast-disintegrating, rapid-release formulation for the acute treatment of migraine: results of a multicenter, randomized, placebo-controlled study.
Carpay J; Schoenen J; Ahmad F; Kinrade F; Boswell D
Clin Ther; 2004 Feb; 26(2):214-23. PubMed ID: 15038944
[TBL] [Abstract][Full Text] [Related]
40. Naratriptan as short-term prophylaxis of menstrually associated migraine: a randomized, double-blind, placebo-controlled study.
Newman L; Mannix LK; Landy S; Silberstein S; Lipton RB; Putnam DG; Watson C; Jöbsis M; Batenhorst A; O'Quinn S
Headache; 2001 Mar; 41(3):248-56. PubMed ID: 11264684
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
